Serum Vitamin D Metabolites in Colorectal Cancer Patients Receiving Cholecalciferol Supplementation: Correlation with Polymorphisms in the Vitamin D Genes

Hormones and Cancer

Volumn 4, Issue 4, 2013, Pages 242-250

  Muindi, Josephia R ^a   Adjei, Araba A ^a   Wu, Zengru R ^a   Olson, Isabel ^a   Huang, Huayi ^a   Groman, Adrienne ^a   Tian, Lili ^a   Singh, Prashant K ^a   Sucheston, Lara E ^a   Johnson, Candace S ^a   Trump, Donald L ^a   Fakih, Marwan G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CHOLESTANETRIOL 26 MONOOXYGENASE; COLECALCIFEROL; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; CYTOCHROME P450 2R1; OXYGENASE; PARATHYROID HORMONE; SECALCIFEROL; STEROID 24 HYDROXYLASE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; COLORECTAL CANCER; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; CHOLECALCIFEROL; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PARATHYROID HORMONE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; SEQUENCE ANALYSIS, DNA; STEROID HYDROXYLASES; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN; VITAMINS;

EID: 84879420000     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-013-0139-9     Document Type: Article

References (36)

1. Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancer and cardiovascular diseases. Am J Clin Nutr 80: 1678S-1688S.
2. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135: 317-322.
3. Goldner WS, Stoner JA, Thompson J, Taylor K, Larson L, Erickson J, McBride C (2008) Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls. Obes Surg 18: 145-150.
4. Linnebur SA, Vondracek SF, Vande Griend JP, Ruscin JM, McDermott MT (2007) Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. Am J Geriatr Pharmacother 5: 1-8.
5. Chen TC, Chimeh F, Lu Z, Mathieu J, Person KS, Zhang A, Kohn N, Martinello S, Berkowitz R, Holick MF (2007) Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 460: 213-217.
6. Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY (2009) Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Color Dis 24: 219-224.
7. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, Albanes D (1997) Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8: 615-625.
8. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci E (2007) A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99: 1120-1129.
9. Moan J, Porojnicu A, Lagunova Z, Berg JP, Dahlback A (2007) Colon cancer: prognosis for different latitudes, age groups and seasons in Norway. J Photochem Photobiol 89: 148-155.
10. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS (2008) Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26: 2984-2991.
11. Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Farin FM, Makar KW, Carlson CS, Caan BJ, Potter JD, Peters U (2009) Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev 18: 2540-2548.
12. Wang TJ, Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O'Reilly PF, Houston DK, Glazer NL, Vandenput L, Peacock M, Shi J, Rivadeneira F, McCarthy MI, Anneli P, de Boer IH, Mangino M, Kato B, Smyth DJ, Booth SL, Jacques PF, Burke GL, Goodarzi M (2010) Common genetic determinants of D insufficient; a genome-wide association study. Lancet 376: 180-188.
13. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB, Li Q, Weinstein SJ, Purdue M, Virtamo J, Horst R, Wheeler W, Chanock S, Hunter DJ, Hayes RB, Kraft P, Albanes D (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19: 2739-2745.
14. McGrath JJ, Saha S, Burne TH, Eyles DW (2010) A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 121: 471-477.
15. Bu FX, Armas L, Lappe J, Zhou Y, Gao G, Wang HW, Recker R, Zhao LJ (2010) Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet 128: 549-556.
16. Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ (1998) Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 7: 385-390.
17. Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE (2009) Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem 42: 1174-1177.
18. Fakih MG, Andrews C, McMahon J, Muindi JR (2012) A prospective clinical trial of cholecalciferol 2000 IU/day in colorectal cancer patients: evidence of a chemotherapy-response interaction. Anticancer Res 32: 1333-1338.
19. 2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clinica Chimica Acta 391: 6-12.
20. 3. Clin Chem 51: 1683-1690.
21. Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL (1999) A Phase I trial of calcitriol (1, 25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res 5: 1339-1345.
22. Muindi JR, Peng Y, Wilson JW, Johnson CS, Branch RA, Trump DL (2007) Monocyte fructose 1, 6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients. Cancer Chemother Pharmacol 59: 97-104.
23. Chung I, Karpf AR, Muindi JR, Conroy JM, Nowak NJ, Johnson CS, Trump DL (2007) Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol. J Biol Chem 282: 8704-8714.
24. nd ASH meeting 2010 Abstract # 1041.
25. Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS (2009) Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int 104: 909-914.
26. Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, Davis W, Hong CC, McCann SE, Hwang H, Kulkarni S, Edge SB, O'Connor TL, Ambrosone CB (2011) Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One 28;6 (2): e17251.
27. Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD (2009) Serum 25-hydroxyvitamin D levels in vitamin D- insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 45: 870-875.
28. Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR (2009) High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 20: 1407-1415.
29. 2D. Amer J Clin Nutr 52: 701-706.
30. Masuda S, Okano T, Kamao M, Kanedai Y, Kobayashi T (1997) A novel high-performance liquid chromatographic assay for vitamin D metabolites using a coulometric electrochemical detector. J Pharmaceut Biomedl Anal 15: 1497-1502.
31. Higashi T, Awada D, Shimada K (2001) Determination of 24, 25-dihydroxyvitamin D3 in human plasma using liquid chromatography-mass spectrometry after derivatization with a Cookson-type reagent. Biomed Chromatogr 15: 133-140.
32. 3 metabolism. FEBS J 272: 4080-4090.
33. Guryev O, Carvalho RA, Usanov S, Gilep A, Estabrook RW (2003) A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc Natl Acad Sci U S A 100: 14754-14759.
34. Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP (1995) Serum levels of free 1, 25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med 122: 511-513.
35. White P, Cooke N (2000) The multifunctional properties and characteristics of vitamin D-binding protein. TEM 11: 320-327.
36. Haddad JG (1995) Plasma vitamin D-binding protein (GC-globulin): multiple tasks. J Steroid Biochem Mol Biol 53: 579-582.